Download lung cancer

LUNG CANCER
TREATMENT UPDATE 2004
If you would be interested in receiving the following monthly Current Awareness
Bulletins by email please contact [email protected]
Cancer Pain
Cancer: Supportive Care
Gynaecologic Oncology
Lung Cancer
Access Lung Cancer Treatment Update 2004 here
Lung Cancer Treatment Update 2004 is available via the NHS Scotland e-Library
MKN Cancer Portal by clicking Current Awareness on the Left Hand Side Menu Bar.
This booklet was produced by Kirsty Coltart, Clinical Librarian,
Beatson Oncology Centre, North Glasgow Library and E-Learning Service
Reviews and trials in 2004 have been scanned and highlights selected. All of the
articles can be found full text on the NHS Scotland e-Library.
NHS Scotland ATHENs Username & Password is required for full text, register at:
http://www.elib.scot.nhs.uk
Drug Therapy
Agelaki S. A multicenter phase II study of the combination of irinotecan and gemcitabine in
previously treated patients with small-cell lung cancer. Oncology. 66(3):192-6, 2004.
Agelaki S. A multicenter phase II study of the combination of gemcitabine and docetaxel in
previously treated patients with small cell lung cancer. Lung Cancer. 43(3):329-33, 2004 Mar.
Ando M. Weekly administration of irinotecan (CPT-11) plus cisplatin for refractory or relapsed
small cell lung cancer. Lung Cancer. 44(1):121-7, 2004 Apr.
Ardizzoia A. Second line therapy with weekly low-dose docetaxel for pretreated non-smallcell lung carcinoma patients: a multicenter Italian phase II study. Lung. 182(1):1-8, 2004.
Bidoli P. Phase I study of escalating doses of oxaliplatin in combination with fixed dose
gemcitabine in patients with non-small cell lung cancer. Lung Cancer. 43(2):203-8, 2004 Feb.
Bourgeois H. Phase I study with dose escalation of gemcitabine and cisplatin in combination
with ifosfamide (GIP) in patients with non-small-cell lung carcinoma. American Journal of
Clinical Oncology. 27(1):89-95, 2004 Feb.
Cakir S. A randomised clinical trial of radiotherapy plus cisplatin versus radiotherapy alone in
stage III non-small cell lung cancer. Lung Cancer. 43(3):309-16, 2004 Mar.
Cappuzzo F. Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced
non-small-cell lung cancer (NSCLC). British Journal of Cancer. 90(1):82-6, 2004 Jan 12.
Ceresoli GL. Phase II study of weekly paclitaxel as second-line therapy in patients with
advanced non-small cell lung cancer. Lung Cancer. 44(2):231-9, 2004 May.
Chen YM. A randomised phase II study of weekly paclitaxel or vinorelbine in combination
with cisplatin against inoperable non-small-cell lung cancer previously untreated. British
Journal of Cancer. 90(2):359-65, 2004 Jan 26.
Comella P. Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine
alone for elderly or unfit advanced non-small-cell lung cancer patients. British Journal of
Cancer. 91(3):489-97, 2004 Aug 2.
Cortes J. Paclitaxel, cisplatin, and vinorelbine combination chemotherapy in metastatic nonsmall-cell lung cancer. American Journal of Clinical Oncology. 27(3):299-303, 2004 Jun.
Delbaldo C. Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen
in advanced non-small-cell lung cancer: a meta-analysis. JAMA. 292(4):470-84, 2004 Jul 28.
Georgoulias V. Irinotecan plus gemcitabine vs irinotecan for the second-line treatment of
patients with advanced non-small-cell lung cancer pretreated with docetaxel and cisplatin: a
multicentre, randomised, phase II study. British Journal of Cancer. 91(3):482-8, 2004 Aug 2.
Giaccone G. Glufosfamide administered by 1-hour infusion as a second-line treatment for
advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development
Group. European Journal of Cancer. 40(5):667-72, 2004 Mar.
Ikehara M. Phase II study of OK-432 intrapleural administration followed by systemic cisplatin
and gemcitabine for non-small cell lung cancer with pleuritis carcinomatosa. Journal of
Experimental Therapeutics & Oncology. 4(1):79-83, 2004 Apr.
Janne PA. Outcomes of patients with advanced non-small cell lung cancer treated with
gefitinib (ZD1839, "Iressa") on an expanded access study. Lung Cancer. 44(2):221-30, 2004
May.
Johnson E. Phase II trial of vinorelbine plus doxorubicin in relapsed small-cell lung cancer:
CALGB 9332. American Journal of Clinical Oncology. 27(1):19-23, 2004 Feb.
Kato H. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma
of the lung. New England Journal of Medicine. 350(17):1713-21, 2004 Apr 22.
Kanard A. Oral vinorelbine for the treatment of metastatic non-small cell lung cancer in
elderly patients: a phase II trial of efficacy and toxicity. Lung Cancer. 43(3):345-53, 2004 Mar.
Katakami N. Combination chemotherapy of gemcitabine and vinorelbine for patients in stage
IIIB-IV non-small cell lung cancer: a phase II study of the West Japan Thoracic Oncology
Group (WJTOG) 9908. Lung Cancer. 43(1):93-100, 2004 Jan.
Kurata T. Combination phase I study of nedaplatin and gemcitabine for advanced non-smallcell lung cancer. British Journal of Cancer. 90(11):2092-6, 2004 Jun 1.
Laurie SA. Practice guideline for the role of combination chemotherapy in the initial
management of limited-stage small-cell lung cancer. Lung Cancer. 43(2):223-40, 2004 Feb.
Levitt ML. Phase I study of gemcitabine given weekly as a short infusion for non-small cell
lung cancer: results and possible immune system-related mechanisms. Lung Cancer.
43(3):335-44, 2004 Mar.
Nishina T. The ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase in
tumour tissues of patients with metastatic gastric cancer is predictive of the clinical response
to 5'-deoxy-5-fluorouridine. European Journal of Cancer. 40(10):1566-71, 2004 Jul.
Otterson GA. Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and
Leukemia Group B (39807). Lung Cancer. 44(2):251-9, 2004 May.
Paccagnella A. Cisplatin versus carboplatin in combination with mitomycin and vinblastine in
advanced non small cell lung cancer. A multicenter, randomized phase III trial. Lung Cancer.
43(1):83-91, 2004 Jan.
Park YH. Gemcitabine and vinorelbine as second-line therapy for non-small cell lung cancer
after treatment with paclitaxel plus platinum. Japanese Journal of Clinical Oncology.
34(5):245-9, 2004 May.
Punt CJ. RFS2000 (9-nitrocamptothecin) in advanced small cell lung cancer, a phase II study
of the EORTC New Drug Development Group. European Journal of Cancer. 40(9):1332-4,
2004 Jun.
Schumacher A. Combined modality treatment for locally advanced non-small cell lung
cancer: preoperative chemoradiation does not result in a poorer quality of life. Lung Cancer.
44(1):89-97, 2004 Apr.
Schiller J. Retrospective cost analysis of gemcitabine in combination with cisplatin in nonsmall cell lung cancer compared to other combination therapies in Europe. Lung Cancer.
43(1):101-12, 2004 Jan.
Sekine I. Phase I study of cisplatin analogue nedaplatin (254-S) and paclitaxel in patients
with unresectable squamous cell carcinoma. British Journal of Cancer. 90(6):1125-8, 2004
Mar 22.
Stewart DJ. Phase II study of alternating chemotherapy regimens for advanced non-small
cell lung cancer. Lung Cancer. 44(2):241-9, 2004 May.
Yamada K. Dose escalation study of paclitaxel in combination with fixed-dose irinotecan in
patients with advanced non-small cell lung cancer (JCOG 9807). Oncology. 66(2):94-100,
2004.
Yamamoto N. Randomised phase II study of docetaxel/cisplatin vs docetaxel/irinotecan in
advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group Study
(WJTOG9803). British Journal of Cancer. 90(1):87-92, 2004 Jan 12.
Yoshimura N. Phase I/II study of cisplatin combined with weekly paclitaxel in patients with
advanced non-small-cell lung cancer. British Journal of Cancer. 90(6):1184-9, 2004 Mar 22.
Zinner RG. Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and
findings regarding optimal identification of patients with Her2-overexpressing disease. Lung
Cancer. 44(1):99-110, 2004 Apr.
Multi-Modality Therapy
Arriagada R. Cisplatin-based adjuvant chemotherapy in patients with completely resected
non-small-cell lung cancer. New England Journal of Medicine. 350(4):351-60, 2004 Jan 22.
Bogart JA. 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limitedstage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808.
International Journal of Radiation Oncology, Biology, Physics. 59(2):460-8, 2004 Jun 1.
Natale RB. Epidermal growth factor receptor-targeted therapy with ZD1839: symptom
improvement in non-small-cell lung cancer. International Journal of Radiation Oncology,
Biology, Physics. 59(2 Suppl):39-43, 2004.
Okawara G. Postoperative radiotherapy in stage II or IIIA completely resected non-small cell
lung cancer: a systematic review and practice guideline. Lung Cancer. 44(1):1-11, 2004 Apr.
Sakai H. Phase II study of bi-weekly docetaxel and carboplatin with concurrent thoracic
radiation therapy followed by consolidation chemotherapy with docetaxel plus carboplatin for
stage III unresectable non-small cell lung cancer. Lung Cancer. 43(2):195-201, 2004 Feb.
Schwarzenberger P. Dose escalation of docetaxel concomitant with hypofractionated, once
weekly chest radiotherapy for non-small-cell lung cancer: a phase I study. American Journal
of Clinical Oncology. 27(4):395-9, 2004 Aug.
Tada H. A randomized trial comparing adjuvant chemotherapy versus surgery alone for
completely resected pN2 non-small cell lung cancer (JCOG9304). Lung Cancer. 43(2):16773, 2004 Feb.
Radiotherapy/Radiology
Akeboshi M. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic
response. Journal of Vascular & Interventional Radiology. 15(5):463-70, 2004 May.
Bydder S. A randomised trial of single-dose radiotherapy to prevent procedure tract
metastasis by malignant mesothelioma. British Journal of Cancer. 91(1):9-10, 2004 Jul 5.
Chen GY. Escalated hyperfractionated accelerated radiation therapy for locally advanced
non-small cell lung cancer: a clinical phase II trial. Radiotherapy & Oncology. 71(2):157-62,
2004 May.
Koto M. Local control and recurrence of stage I non-small cell lung cancer after carbon ion
radiotherapy. Radiotherapy & Oncology. 71(2):147-56, 2004 May.
Narayan S. Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose
escalation study for non-small cell lung cancer. Lung Cancer. 44(1):79-88, 2004 Apr.
Rodrigues G. Prediction of radiation pneumonitis by dose - volume histogram parameters in
lung cancer--a systematic review. Radiotherapy & Oncology. 71(2):127-38, 2004 May.
Schild SE. Long-term results of a phase III trial comparing once-daily radiotherapy with twicedaily radiotherapy in limited-stage small-cell lung cancer. International Journal of Radiation
Oncology, Biology, Physics. 59(4):943-51, 2004 Jul 15.
Senan S. Literature-based recommendations for treatment planning and execution in highdose radiotherapy for lung cancer. Radiotherapy & Oncology. 71(2):139-46, 2004 May.
Thirion P. Escalated dose for non-small-cell lung cancer with accelerated hypofractionated
three-dimensional conformal radiation therapy. Radiotherapy & Oncology. 71(2):163-6, 2004
May.
Surgery
Guggino G. Completion pneumonectomy in cancer patients: experience with 55 cases.
European Journal of Cardio-Thoracic Surgery. 25(3):449-55, 2004 Mar.
Hirata T. Suppression of postoperative systemic inflammatory response syndrome with
clarithromycin following lung cancer surgery. European Surgical Research. 36(1):13-9, 2004
Jan-Feb.
Keller SM. Prolonged survival in patients with resected non-small cell lung cancer and singlelevel N2 disease. Journal of Thoracic & Cardiovascular Surgery. 128(1):130-7, 2004 Jul.
Ohtsuka T. Is major pulmonary resection by video-assisted thoracic surgery an adequate
procedure in clinical stage I lung cancer?. Chest. 125(5):1742-6, 2004 May.
Steinke K. Percutaneous imaging-guided radiofrequency ablation in patients with colorectal
pulmonary metastases: 1-year follow-up. Annals of Surgical Oncology. 11(2):207-12, 2004
Feb.
Waller D. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of
the Big Lung Trial. European Journal of Cardio-Thoracic Surgery. 26(1):173-82, 2004 Jul.
Yasufuku K. Real-time endobronchial ultrasound-guided transbronchial needle aspiration of
mediastinal and hilar lymph nodes. Chest. 126(1):122-8, 2004 Jul.